Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;104(5):2995-3000.
doi: 10.1007/s00277-025-06364-4. Epub 2025 Apr 21.

A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review

Affiliations
Review

A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review

Yu Jiao et al. Ann Hematol. 2025 May.

Abstract

Congenital factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder characterized by prolonged prothrombin time (PT) and reduced FVII coagulant activity (FVII: C). Here, we present the case of a middle-aged male patient with gastrointestinal bleeding, who exhibited prolonged PT and decreased FVII: C levels. Gene sequencing analysis revealed compound heterozygous mutations in the F7 gene: c.64G > A (p.V22I) and c.506-1G > A. Based on the laboratory results and gene sequencing, the patient was diagnosed as FVII deficiency. After adding recombinant activated FVII (rFVIIa) for several days, the laboratory indicators returned to normal and the bleeding symptoms were relieved. In subsequent validation studies, we also identified the c.506-1G > A mutation in his older sister and daughter. Importantly, this represents the first documented case where both mutations coexist concurrently. Additionally, our literature review reveals that approximately 50% of mutation types associated with congenital FVII deficiency are located on exon 9; however, there is no significant correlation between the reduction in FVII: C levels and severity of clinical symptoms based on EAHAD database analysis.

Keywords: Case report; Congenital factor VII deficiency; EAHAD; Prothrombin time.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical standards and consent to publish declaration: The studies involving participant was reviewed and approved by the Ethics Committee of The First Hospital of China Medical University. The patient and his family provided their written informed consent to take part in this study. A copy of the written consent is available for review by the editorial office of this journal. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The pedigree of the family
Fig. 2
Fig. 2
Gene sequencing and verification results. c.64G > A (p.V22I) and c.506-1G > A are marked with a red row
Fig. 3
Fig. 3
The mutation sites and the number of mutations for all cases in the EAHAD database

Similar articles

References

    1. Palla R, Peyvandi F, Shapiro AD (2015) Rare bleeding disorders: diagnosis and treatment [J]. Blood 125(13):2052–2061 - PubMed
    1. Sevenet PO, Kaczor DA, Depasse F, Factor VII, Deficiency (2017) From basics to clinical laboratory diagnosis and patient management [J]. Clin Appl Thromb Hemost 23(7):703–710 - PubMed
    1. Bernardi F, Mariani G (2021) Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis [J]. Haematologica 106(2):351–362 - PMC - PubMed
    1. Mariani G, Bernardi F, Factor VII, Deficiency (2009) [J] Semin Thromb Hemost 35(4):400–406 - PubMed
    1. Giansily-Blaizot M, Rallapalli PM, Perkins SJ et al (2020) The EAHAD blood coagulation factor VII variant database [J]. Hum Mutat 41(7):1209–1219 - PubMed

LinkOut - more resources